Evaluation of the effect of a natural product called Capsule 4 of edible fungi based on Ganoderma, Lentinula edodes, Trametes versicolor, Grifola frondosa on clinical and laboratory symptoms, respiratory and prognosis of patients with coronavirus and monkeypox referred to the Infectious Diseases Clinic of Imam Reza Hospital in 2022

Phase 3

Recruiting

Conditions: COVID-19.
Severe Acute Respiratory Syndrome coronavirus
RA01.0

Registration Number: IRCT20211020052819N1

Lead Sponsor: Artesh University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 100

Inclusion Criteria

Admission for COVID-19 patients, ranging in age from 18 to 70 years,
No history for diabetes, hypertension, smoking, hypertension
Positive PCR test for COVID-19

Exclusion Criteria

Patients with very large lung involvement and severe general condition and should be admitted to the intensive care unit.
Reluctance to continue the plan
Side effects that can cause the patient to stop the plan or leave the study after taking the supplement
Creating any unwanted digestive problems including heartburn, nausea, nausea, vomiting, diarrhea, etc.
Any allergies, whether skin, respiratory or other
Creating any side effects that did not exist before taking the supplement

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DH. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: blood test.;CBC diff. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: blood test.;Na/ k/ Ca / SGOT / SGPT / Creatine / FBS/ Urea. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: blood test.;ESR1. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: blood test.;CRP. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: blood test.;Weakness and nausea. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: check list.

Secondary Outcome Measures

Name	Time	Method
Determining the effect of supplementation on the amount of oxygen. Timepoint: 5 Days. Method of measurement: Pulse oximeter.;General condition of people and vitality after treatment. Timepoint: 5 Days. Method of measurement: En Examination and history.